Biotech

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 17.10.2022.

Facioscapulohumeral muscular dystrophy
Health care
Dot-com bubble
Accounting analyst
United States
Market capitalization

@Biotechnology shared
On Oct 12, 2022
Money on the Move: Vita, scPharmaceuticals, Andera and More https://t.co/niTcLwBWb7 https://t.co/NnJyOXqSYb
Open
Money on the Move: Vita, scPharmaceuticals, Andera and More

Money on the Move: Vita, scPharmaceuticals, Andera and More

​​​​​​​This week, financing came in the form of loans, private placements and a Series B, throwing support behind an injectable heart failure drug, oral immunology therapies and an ASD ...

@BIODeutschland shared
On Oct 12, 2022
RT @Citeline: The European clinical research landscape is quickly transforming. As a sponsor, how do you adapt while ensuring you meet your bottom line? @BIODeutschland https://t.co/tWV4B9loy9 https://t.co/wQR6eAIf6x
Open
Expanding Patient Pools while Navigating Regulatory Landscapes in the European Market

Expanding Patient Pools while Navigating Regulatory Landscapes in the European Market

Their discussion will highlight a study struggling to recruit rare disease patients in Germany during the height of the COVID-19 pandemic and the tactics used to: Enhance trial …

@SWLifeSciences shared
On Oct 13, 2022
Read more to discover why H.C Wainright & Co. believes this stock is a Buy with a target price over 3X the current. Biotech Co.'s Target Price Over Three Times Current: https://t.co/Mu8sbSaKOV $PDSB @PDSBiotech
Open
Biotech Co.'s Target Price Over Three Times Current Research Report

Biotech Co.'s Target Price Over Three Times Current Research Report

Expanded interim data are consistent with previously reported results from the same study, noted an H.C. Wainwright & Co. report.

@SWLifeSciences shared
On Oct 11, 2022
Chen Lin reveals his stock picks for the home stretch of 2022. Chen Reveals His Picks for Last Quarter: https://t.co/uswP4mkHMP $TCDA $AMRS $SNPX $AXSM $GGD:TSX $GSVR.V $AGX.V #biotech #silver #gold #stocks @synaptogenix @axsome @GoGoldResources @GSilver_co @Silver_X_Mining
Open
Chen Reveals His Picks for Last Quarter

Chen Reveals His Picks for Last Quarter

Asset manager Chen Lin's picks for the home stretch of 2022 include several biotechs and some precious metals companies.

Read more:
weekly 17.10.2022
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy